[go: up one dir, main page]

ES2058450T3 - Compuestos de quinoxalina y su preparacion y uso. - Google Patents

Compuestos de quinoxalina y su preparacion y uso.

Info

Publication number
ES2058450T3
ES2058450T3 ES89121911T ES89121911T ES2058450T3 ES 2058450 T3 ES2058450 T3 ES 2058450T3 ES 89121911 T ES89121911 T ES 89121911T ES 89121911 T ES89121911 T ES 89121911T ES 2058450 T3 ES2058450 T3 ES 2058450T3
Authority
ES
Spain
Prior art keywords
compounds
preparation
quinoxaline compounds
hydrogen
diethydrokinoxaline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89121911T
Other languages
English (en)
Inventor
Tage Honore
Poul Jacobsen
Flemming Elmelund Nielsen
Lars Naerum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2058450T3 publication Critical patent/ES2058450T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Television Signal Processing For Recording (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPUESTOS DE DIHIDROQUINOXALINA HETEROCICLICA DE FORMULA (I), DONDE: R1 ES HIDROXI, ALCOXI, ARILOXI, ARALCOXI, CICLOALQULALCOXI, CICLOALCOXI O ACILOXI; R5, R6, R7 Y R8 SON INDEPENDIENTEMENTE HIDROGENO, NO2, HALOGENO, CN, SO2NR''R'', SO2R'', CF3, O OR DONDE R'' ES HIDROGENO O ALQUIL C 1-4. LA INVENCION TAMBIEN TRATA DEL METODO PARA PREPARAR EL COMPUESTO, LA COMPOSICION FARMACEUTICA DEL MISMO Y SU USO. LOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE INDICIOS CAUSADOS POR HIPERACTIVIDAD DE LOS NEUROTRANSMISORES EXCITATORIOS.
ES89121911T 1988-12-22 1989-11-28 Compuestos de quinoxalina y su preparacion y uso. Expired - Lifetime ES2058450T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK715888A DK715888D0 (da) 1988-12-22 1988-12-22 Quinoxalinforbindelser, deres fremstilling og anvendelse

Publications (1)

Publication Number Publication Date
ES2058450T3 true ES2058450T3 (es) 1994-11-01

Family

ID=8149230

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89121911T Expired - Lifetime ES2058450T3 (es) 1988-12-22 1989-11-28 Compuestos de quinoxalina y su preparacion y uso.

Country Status (16)

Country Link
US (1) US5061706A (es)
EP (1) EP0377112B1 (es)
JP (1) JPH02221263A (es)
AT (1) ATE110371T1 (es)
AU (1) AU626093B2 (es)
CA (1) CA2004078A1 (es)
DE (1) DE68917708T2 (es)
DK (1) DK715888D0 (es)
ES (1) ES2058450T3 (es)
FI (1) FI896235A7 (es)
IE (1) IE66561B1 (es)
IL (1) IL92463A (es)
NO (1) NO178661C (es)
NZ (1) NZ231906A (es)
PT (1) PT92714B (es)
ZA (1) ZA899469B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK69790D0 (da) * 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse
HU221425B (en) * 1990-11-06 2002-10-28 Yamanouchi Pharma Co Ltd Condensed pyrazine derivatives, process for their production and pharmaceutical preparations containing these compounds
PT99864B (pt) 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
JP3301024B2 (ja) * 1992-06-22 2002-07-15 ザ・リージェンツ・オブ・ザ・ユニバーシテイ・オブ・カリフォルニア グリシンレセプター拮抗物質及びその用途
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
EP0705834A1 (de) * 1994-07-27 1996-04-10 Ciba-Geigy Ag Azaaliphatisch Überbrückte Chinoxalin-2,3-dione
EP0705835A1 (de) * 1994-09-01 1996-04-10 Ciba-Geigy Ag Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione
GB9418443D0 (en) * 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
DE4436852A1 (de) * 1994-10-14 1996-04-18 Basf Ag Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
AU3166897A (en) * 1996-06-24 1998-01-14 Novo Nordisk A/S Factor vii-binding reagent
US5922715A (en) * 1997-02-18 1999-07-13 American Home Products Corporation 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones
JP2001511805A (ja) * 1997-02-18 2001-08-14 アメリカン・ホーム・プロダクツ・コーポレイション ドパミン作動薬である５−アミノアルコキシ−１，４−ジヒドロキノキサリン−２，３−ジオン
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) * 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4812458A (en) * 1986-09-16 1989-03-14 A/S Ferrosan 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser

Also Published As

Publication number Publication date
FI896235A7 (fi) 1990-06-23
IL92463A0 (en) 1990-08-31
PT92714A (pt) 1990-06-29
NO895193L (no) 1990-06-25
IE893749L (en) 1990-06-22
ZA899469B (en) 1990-09-26
CA2004078A1 (en) 1990-06-22
JPH02221263A (ja) 1990-09-04
AU4687289A (en) 1990-06-28
AU626093B2 (en) 1992-07-23
PT92714B (pt) 1996-01-31
EP0377112B1 (en) 1994-08-24
NO178661C (no) 1996-05-08
NO895193D0 (no) 1989-12-21
IL92463A (en) 1995-03-15
FI896235A0 (fi) 1989-12-22
IE66561B1 (en) 1996-01-24
EP0377112A1 (en) 1990-07-11
ATE110371T1 (de) 1994-09-15
NO178661B (no) 1996-01-29
DE68917708D1 (de) 1994-09-29
DE68917708T2 (de) 1994-12-15
NZ231906A (en) 1991-11-26
DK715888D0 (da) 1988-12-22
US5061706A (en) 1991-10-29

Similar Documents

Publication Publication Date Title
ES2058450T3 (es) Compuestos de quinoxalina y su preparacion y uso.
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
ES2057076T3 (es) Compuestos de quinoxalina y su preparacion y empleo.
ES2037753T3 (es) Compuestos heterociclicos y su preparacion y uso.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
ES542321A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil-1-piperazina
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
ES2147759T3 (es) Heterociclos no aromaticos sustituidos con aminometileno y uso como antagonistas de la sustancia p.
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
ES2153820T3 (es) Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones.
DE69006052D1 (de) 19-Nor-Vitamin-D-Derivate.
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
AR231987A1 (es) Procedimiento para preparar derivados farmaceuticos de pirrolo-2,1-c 1,4 tiazepin-1,5-diona y compuesto intermediario para uso exclusivo en el mismo
ES2123652T3 (es) 7-(2-aminoetil)-benzotiazolonas.
ES2051479T3 (es) Uso de imidazoles substituidos en 4 para disminuir la presion intraocular.
DE3887151D1 (de) Inhibitoren für zellenzuwachs und methoden für krebsbehandlung.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
AR219561A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-piperidino-6,7-dialcoxi-ftalazina utiles como agentes terapeuticos
ES2090012T3 (es) Derivados de propoxibenceno y procedimiento para la preparacion de los mismos.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
ES537205A0 (es) Procedimiento para preparar derivados de purina
ES491960A0 (es) Procedimiento para la obtencion de derivados de sisomicina
ES2074508T3 (es) Benzocicloalquilaminopiridinaminas y compuestos afines, un procedimiento e intermediarios para su preparacion y su uso como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 377112

Country of ref document: ES